pharmaphorum

JANUARY 6, 2022

The latest pharma company to make a move for an mRNA specialist is Germany’s Merck KGaA, which has offered a $780 million cash buyout to US biotech Exelead. Outsourcing services are on of the pillars of Merck’s business, delivered via its process solutions unit, part of the group’s life sciences division.

Vaccination 98

Vaccination Vaccine Manufacturing Life Science 98

pharmaphorum

NOVEMBER 30, 2022

Veeva Systems invited pharmaphorum to attend its industry summit in Madrid this week, a huge event that gathered together over 1,000 individuals from life sciences and pharma. The question is, how can the journey there be accelerated, when on the horizon awaits a life sciences future very much immersed in speciality medicine?

Life Science 98

Life Science Pharma Companies Sales Marketing 98

pharmaphorum

NOVEMBER 15, 2022

On 14th November, investors and life science & healthcare executives descended on London’s famed Old Billingsgate building to attend LSX’s Inv€$tival Showcase, part of Europe’s biggest dedicated healthcare investment week. Investing in the future of the European life sciences. For Müllenbeck, this is an opportunity.

Life Science 92

Life Science Pharma Companies Marketing Production 92

XTalks

MARCH 22, 2023

In October 2022, Xtalks celebrated two decades of bringing diverse stakeholders in the life science industry together through first holding physical events, then soon after, hosting exclusively online events. Pfizer is also the co-developer of what is arguably the most successful COVID-19 vaccine rollout.

Life Science 97

Life Science Drugs FDA Approval Vaccination 97

pharmaphorum

DECEMBER 16, 2022

Further, with a pandemic treaty in development, there are reasons to believe that many countries and the WHO want to see a more equitable distribution of medical products for future pandemics. The industry has so far resisted demands for the sharing of intellectual property (IP) around products developed to counter the pandemic.

Vaccination 94

Vaccination Vaccine Production Licensing 94

XTalks

FEBRUARY 15, 2024

US Senator Bernie Sanders, who chairs the Health, Education, Labor, and Pensions (HELP) Committee, managed to bring CEOs of major American pharma companies to a committee hearing to discuss exorbitant US drug pricing. These are the guys developing cures.”

Drugs 52

Drugs Pharma Companies Pharmacy Regulation 52

XTalks

DECEMBER 13, 2023

In 2023, biotechnology and pharmaceutical companies leverage cutting-edge technology and significant investments in research and development (R&D) to continue pushing the boundaries of innovation in the healthcare sector, transcending the challenges posed by the pandemic.

Genetics 111

Genetics Vaccination Vaccine DNA 111

pharmaphorum

SEPTEMBER 18, 2020

But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca.

Pharma Companies 116

Pharma Companies Sales Vaccination Vaccine 116

pharmaphorum

APRIL 19, 2022

In 2022, pharma is truly a global industry, and innovation can come from anywhere. But for small life sciences outside of the USA and Europe, it can still be challenging to break onto this global stage. The company recently raised $16.5 The company’s second drug candidate, RCI002, is focused on chronic pain.

Marketing 52

Marketing Clinical Trials Clinical Trials Licensing 52

pharmaphorum

AUGUST 25, 2021

Jirair Ratevosian, executive director of global patient solutions and government affairs at Gilead Sciences, tells us how his company utilised previously developed partnerships and their knowledge of providing global access to HIV treatments to distribute Remdesivir. It’s not a coincidence that we now have over 2.3

Marketing 52

Marketing Licensing Licensing Manufacturing 52

pharmaphorum

MAY 27, 2022

The development of guidance to support companies who require risk assessments when working with clinical trial data on selected computerised systems is welcomed. There is a huge opportunity for pharma companies to capitalise on by focusing on increased DEI in clinical trials. What comes next?

Clinical Trials 80

Clinical Trials Clinical Trials Trials Packaging 80

XTalks

AUGUST 21, 2023

Development of medicines for rare diseases takes commitment and belief from everyone involved. Ipsen is also concurrently working on an investigational FOP drug, BLU-782, which they have licensed from Blueprint Medicines Corp.

Drugs 98

Drugs FDA Approval Genetics Clinical Trials 98

pharmaphorum

MAY 14, 2021

“While NICE’s first target is the UK NHS, this information can also be useful for other EU health services – especially when a country has not developed its own guidance – and even the US, where evaluation from the institute for clinical and economic review becoming more important, using NICE principles of CEA/CUA.”.

Marketing 59

Marketing Regulation Medicine Life Science 59

Drug Discovery World

OCTOBER 7, 2022

It is about going faster in progressing our innovation to market, taking things further along the value chain as we de-risk the early science. It’s about working together with our partners in the life science sector to get world class innovations to patients. . Hamish Ryder. Our commercial setup is rare.

HR 52

HR Research Drugs Development 52

Pharmaceutical Technology

JANUARY 25, 2023

In 2020 and 2021, there was a boom in biotech companies going public. “We We had over 100 companies go public in the sector in 2020 and 2021. Many of those companies were uncharacteristically early in development,” notes Barbara Ryan, senior advisor of Life Sciences at Ernst & Young.

Marketing 173

Marketing Life Science Pharma Companies Licensing 173

Pharmaceutical Technology

MAY 26, 2023

After raising $125m in 2021 to redevelop the facility, more recently Touchlight secured an additional $17.3m (£14m) from the UK government’s Life Sciences Innovative Manufacturing Fund to accelerate its expansion plans and scale-up equipment.

DNA 130

DNA Manufacturing Gene Therapy Gene 130